{"id":16299,"date":"2018-05-23T08:27:35","date_gmt":"2018-05-23T08:27:35","guid":{"rendered":"http:\/\/thepatientinvestor.com\/?p=16299"},"modified":"2018-05-23T08:27:35","modified_gmt":"2018-05-23T08:27:35","slug":"price-earnings-the-race-to-the-top","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/","title":{"rendered":"Price &#038; Earnings: The Race to the Top"},"content":{"rendered":"<p>Now that 93% of S&amp;P 500 stocks have reported first quarter earnings we can look at price-earnings valuation with a fair degree of confidence. My favorite is what I call PEMax, which  compares Price to Maximum Annual Earnings for current and past years. This removes distortions caused by periods when earnings fall faster than price, by focusing on earnings potential rather than necessarily the most recent earnings performance.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"PE of Maximum Earnings\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png?w=525&#038;ssl=1\" \/><\/p>\n<p>Valuations are still high, but PEMax has pulled back to 22.78 from 24.16 in the last quarter. Valuations remain at their highest over the last 100 years at any time other than during the Dotcom bubble. Even during the 1929 Wall Street crash (Black Friday) and Black Monday of October 1987, PEMax was below 20.<\/p>\n<p>While that warns us to be cautious, as valuations are high, it does not warn of an imminent down-turn. Markets react more to earnings than to prices as the chart below illustrates.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"S&amp;P 500 Earnings per Share Growth\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2018-05-18-epsgrowth.png?w=525&#038;ssl=1\" \/><\/p>\n<p>The last two market down-turns were both precipitated by falling earnings &mdash; the blue columns on the above chart &mdash; rather than valuations.<\/p>\n<p>While it is concerning that prices have run ahead of EPS &mdash; as they did during the late 1990s &mdash; consolidation over the past quarter should allow earnings room to catch up.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Now that 93% of S&amp;P 500 stocks have reported first quarter earnings we can look at price-earnings valuation with a fair degree of confidence. My favorite is what I call PEMax, which compares Price to Maximum Annual Earnings for current and past years. This removes distortions caused by periods when earnings fall faster than price, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Price &#038; Earnings: The Race to the Top&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[48,57,34],"tags":[1154,3766,2750,3010],"class_list":["post-16299","post","type-post","status-publish","format-standard","hentry","category-earnings-dividends","category-stock-markets","category-us-canada-countries-regions","tag-earnings","tag-pemax","tag-price-earnings-ratio","tag-sp-500"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Price &amp; Earnings: The Race to the Top - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Price &amp; Earnings: The Race to the Top - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Now that 93% of S&amp;P 500 stocks have reported first quarter earnings we can look at price-earnings valuation with a fair degree of confidence. My favorite is what I call PEMax, which compares Price to Maximum Annual Earnings for current and past years. This removes distortions caused by periods when earnings fall faster than price, &hellip; Continue reading &quot;Price &#038; Earnings: The Race to the Top&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-23T08:27:35+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Price &#038; Earnings: The Race to the Top\",\"datePublished\":\"2018-05-23T08:27:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/\"},\"wordCount\":211,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png\",\"keywords\":[\"earnings\",\"PEMAX\",\"price-earnings ratio\",\"S&amp;P 500\"],\"articleSection\":[\"Earnings &amp; Dividends\",\"Stock Markets\",\"US &amp; Canada\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/\",\"name\":\"Price & Earnings: The Race to the Top - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png\",\"datePublished\":\"2018-05-23T08:27:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Price &#038; Earnings: The Race to the Top\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\",\"https:\/\/au.linkedin.com\/in\/colintwiggs\"],\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Price & Earnings: The Race to the Top - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Price & Earnings: The Race to the Top - the patient investor","og_description":"Now that 93% of S&amp;P 500 stocks have reported first quarter earnings we can look at price-earnings valuation with a fair degree of confidence. My favorite is what I call PEMax, which compares Price to Maximum Annual Earnings for current and past years. This removes distortions caused by periods when earnings fall faster than price, &hellip; Continue reading \"Price &#038; Earnings: The Race to the Top\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2018-05-23T08:27:35+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Price &#038; Earnings: The Race to the Top","datePublished":"2018-05-23T08:27:35+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/"},"wordCount":211,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png","keywords":["earnings","PEMAX","price-earnings ratio","S&amp;P 500"],"articleSection":["Earnings &amp; Dividends","Stock Markets","US &amp; Canada"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/","name":"Price & Earnings: The Race to the Top - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png","datePublished":"2018-05-23T08:27:35+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2018-05-18-pemax.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Price &#038; Earnings: The Race to the Top"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-4eT","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":23779,"url":"https:\/\/thepatientinvestor.com\/index.php\/2021\/01\/21\/sp-500-bubble-risk\/","url_meta":{"origin":16299,"position":0},"title":"S&#038;P 500 bubble risk","author":"Colin Twiggs","date":"January 21, 2021","format":false,"excerpt":"S&P 500 valuations are higher than the 1929 (Black Friday) Wall Street crash and the October 1987 (Black Monday) crash. The Dotcom bubble is the only time in the last 120 years that the ratio between Price and highest trailing earnings (PEmax) was higher. PEmax eliminates distortions in the price\/earnings\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16039,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/12\/09\/cape-v-pemax-how-hot-are-market-valuations\/","url_meta":{"origin":16299,"position":1},"title":"CAPE v PEMAX: How hot are market valuations?","author":"Colin Twiggs","date":"December 9, 2017","format":false,"excerpt":"Robert Shiller's CAPE ratio is currently at 32.17, the second-highest peak in recorded history. According to multpl.com, prior to the Black Tuesday crash of 1929 CAPE had a reading of 30. The only peak with a higher reading is the Dotcom bubble at 44. Click here to view at multpl.com.\u2026","rel":"","context":"In &quot;Quotes&quot;","block_context":{"text":"Quotes","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/quotes\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":21187,"url":"https:\/\/thepatientinvestor.com\/index.php\/2020\/08\/07\/sp-500-pemax-at-24\/","url_meta":{"origin":16299,"position":2},"title":"S&#038;P 500 PEmax at 24","author":"Colin Twiggs","date":"August 7, 2020","format":false,"excerpt":"The S&P 500 is way over-priced based on all three earnings multiples. 75% of companies in the S&P 500 have already reported earnings, so we have a good idea as to what overall earnings will be for the second quarter. Based on the latest index price of 3349.16, trailing PE\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17741,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/01\/15\/pemax-why-you-should-be-cautious-using-robert-shillers-cape\/","url_meta":{"origin":16299,"position":3},"title":"PEmax and why you should be wary of Robert Shiller&#8217;s CAPE","author":"Colin Twiggs","date":"January 15, 2019","format":false,"excerpt":"Robert Shiller's groundbreaking works, Irrational Exuberance and Animal Spirits, led to a Nobel prize in 2013 but we need to be careful of placing too much reliance on his CAPE as an indicator of stock market value. What is CAPE? CAPE is the cyclically adjusted price-to-earnings ratio, normally applied to\u2026","rel":"","context":"In &quot;Earnings &amp; Dividends&quot;","block_context":{"text":"Earnings &amp; Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":26535,"url":"https:\/\/thepatientinvestor.com\/index.php\/2021\/06\/26\/sp-500-and-the-fed-taper\/","url_meta":{"origin":16299,"position":4},"title":"S&#038;P 500 and the Fed taper","author":"Colin Twiggs","date":"June 26, 2021","format":false,"excerpt":"S&P 500 earnings forecasts show a sizable jump in the March quarter (97.3% reported) followed by a weaker June quarter as the economy struggles with supply chain interruptions and labor shortages. Record operating margins of 13.0% estimated for the first quarter (March '21) are unlikely to be repeated. The average\u2026","rel":"","context":"In &quot;GDP and Activity&quot;","block_context":{"text":"GDP and Activity","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/gdp-and-activity\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16826,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/08\/11\/sp-500-earnings-surge\/","url_meta":{"origin":16299,"position":5},"title":"S&#038;P 500 earnings surge","author":"Colin Twiggs","date":"August 11, 2018","format":false,"excerpt":"Of companies in the S&P 500 index, 90.2% have reported their results for the quarter. According to S&P Dow Jones Indices: Sales growth at 11.0% year-on-year (Y\/Y) is close to a potential record. The earnings beat rate of 78% is also historically high, compared to an average of 67%. Operating\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=16299"}],"version-history":[{"count":1,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16299\/revisions"}],"predecessor-version":[{"id":16300,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16299\/revisions\/16300"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=16299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=16299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=16299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}